|
NaropinDrug - Naropin The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; INJECTION
Active Ingredient(s) -
Ropivacaine Hydrochloride Monohydrate
Strength -
2MG/ML
Applicant -
ASTRAZENECA
New Drug Application (NDA) Number -
020533
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Sep 24, 1996
Reference Listed Drug (RLD) -
No
Type -
RX
Applicant Full Name -
Astrazeneca Lp
Naropin
Naropin 10mg/ml Injectable; Injection
Naropin 2mg/ml Injectable; Injection Vioxx 50mg Tablet; Oral Requip Eq 0.25mg Base Tablet; Oral Requip Eq 0.5mg Base Tablet; Oral Requip Eq 1mg Base Tablet; Oral Requip Eq 2mg Base Tablet; Oral Requip Eq 3mg Base Tablet; Oral Requip Eq 4mg Base Tablet; Oral Requip Eq 5mg Base Tablet; Oral NewDrugInformation |